Hormone Replacement Therapy in Healthcare

Running head: HORMONE REPLACEMENT THERAPY IN HEALTHCARE
TOPIC: HORMONE REPLACEMENT THERAPY IN HEALTHCARE
Name of the Student:
Name of the University:
Author Note:

1HORMONE REPLACEMENT THERAPY IN HEALTHCARE
This report is an account of the various risks which is involved in women after changes in
hormonal levels after menopause. Menopause has been a common term associated with the
permanent stoppage of menstrual cycle after midlife or in older women. There are various
therapies included for the convenience of menopausal women. Hormone replacement therapy
is one such method. The following paragraphs will encompass the various risks involve with
the hormonal replacement therapies and the various side effects associated with it alongside
the potential advantages and disadvantages of the mentioned therapy.
Menopause is actually the time period when there is cessation of the menstrual cycle
permanently as a result of the depletion of the ovarian oocytes as a result of aging. This kind
of diagnoses is retrospective of the time women stop having their normal menstrual cycles
from 12 months of the first stoppage. It thus is a mark of end of permanent fertility and the
average age of menopause is usually 51 years. There are various hormonal as well as non-
hormonal therapies. Hormonal therapies include estrogens, progesterone, androgens and
tibolone. Non hormonal theories are inclusive of anticonvulsants, anti-hypertensive s like
clonidine, acupuncture methods, sedatives and soy and herbal supplements. According to
statistics, menopause elated systems pertaining to the genitourinary system affect more than
50% of older women and midlife. Moreover, such statistics vary according to various
countries. In Australia, prevalence of early menopause was 4% whopping to 25% after one
year after menopause as well as 47%, after 3 years after menopause (Portman, Gass and
Vulvovaginal Atrophy Terminology Consensus Conference Panel 2014).
Perimenopause is often followed by fluctuating as well as declining levels of estrogen.
Moreover, there is also varying levels of other steroid hormones which stimulate the
synthesis of various neurotransmitters. In addition there also has been declining levels of
serotonin as well as norepinephrine. One of the important risks is the depressive symptoms
which occur in menopausal transition for women (Dalal and Agarwal 2015).